Example: Heart Attack

Clinical Trials on Thrombocytopenia

Total 392 results

NCT02074436

Recruiting

PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)

Conditions: Hematological Malignancies, Thrombocytopenia
NCT02052882

Active, not recruiting

Study of Romiplostim for Chemotherapy Induced Thrombocytopenia

Conditions: Isolated Chemotherapy-induced Thrombocytopenia
NCT04224688

Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04200456

Recruiting

A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04842760

Not yet recruiting

PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer

Conditions: Platelet Disorder, Heparin-induced Thrombocytopenia, Platelet Activation, Platelet Aggregation
NCT04346654

Recruiting

A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

Conditions: Immune Thrombocytopenia (ITP)
NCT04631211

Recruiting

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Conditions: Thrombocytopenia, Hematologic Malignancy, Bone Marrow Aplasia, Myeloproliferative Disorders, Myelodysplastic Syndromes, Platelet Refractoriness
NCT03937154

Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer

Conditions: Chemotherapy-induced Thrombocytopenia
NCT04638829

Recruiting

Open-label Study Measuring Safety and Treatment Satisfaction in Adult Subjects With Chronic Immune Thrombocytopenia (ITP) After Switching to Avatrombopag From Eltrombopag or Romiplostim

Conditions: Immune Thrombocytopenia
NCT04516967

Recruiting

Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 Months

Conditions: Immune Thrombocytopenia
NCT02717039

Recruiting

Pharmacogenomics of Heparin-Induced Thrombocytopenia

Conditions: Heparin-induced Thrombocytopenia
NCT04268940

Active, not recruiting

Thrombo-Elastography Guided Management of ECMO

Conditions: Extracorporeal Circulation of Blood; Thrombocytopenia
NCT03362177

Recruiting

Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer

Conditions: Chemotherapy-induced Thrombocytopenia
NCT02323178

Completed

A Study of Eltrombopag in Patients With CMML and Thrombocytopenia

Conditions: CMML, Thrombocytopenia
NCT04845659

Not yet recruiting

Avatrombopaq In Patients With Cirrhosis

Conditions: Thrombocytopenia; Drugs, Cirrhosis, Liver, Procedural Bleeding
NCT04562766

Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

Conditions: Immune Thrombocytopenia
NCT03275740

Recruiting

A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347

Conditions: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Primary Immune Thrombocytopenia
NCT04547153

Recruiting

LD-FUD for Highly Aggressive Gastric Cancer

Conditions: Gastric Cancer, Bone Marrow Metastasis, Thrombocytopenia
NCT04188379

Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04225156

Recruiting

A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Conditions: Primary Immune Thrombocytopenia
NCT04687072

Recruiting

A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia

Conditions: Primary Immune Thrombocytopenia
NCT04596995

Enrolling by invitation

A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)

Conditions: Primary Immune Thrombocytopenia
NCT04837703

Available

MAP to Provide Access to Eltrombopag, for Treatment of Patients With Medically Significant Thrombocytopenia

Conditions: Thrombocytopenia
NCT03164915

Completed

A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj. in Primary Immune Thrombocytopenia (ITP)

Conditions: Immune Thrombocytopenia
NCT01286038

Active, not recruiting

Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia

Conditions: Myelodysplastic Syndrome (MDS), Thrombocytopenia